GGrantIndex
← Leaderboards

Brian L Stauffer

University Of Colorado Denver

$5,871,842
Attributed
$10,712,996
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $847.2K · FY200725
$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,712,996 · 6

By mechanism

R01$9,678,609 · 3
K08$616,100 · 1
R21$412,556 · 1
F32$5,731 · 1

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Top investigators on “Heart Failure

Research focus

Heart FailureCardiacSignal TransductionAnimal ModelAdultMediatingMolecularChildhoodHeartClinical CareMyocardiumMorbidity - Disease RateMyocardialResponseCardiac MyocytesClinical TrialsNational Heart, Lung, And Blood InstituteGenerationsBasePreventMouse ModelPhysiologyHeart DiseasesMortality Vital Statistics

Grant awards (28)

Targeting Mitochondria in Single Ventricle Heart Disease$650,943
R01 · FY2025 · HL
Targeting Mitochondria in Single Ventricle Heart Disease$651,604
R01 · FY2024 · HL
Targeting Mitochondria in Single Ventricle Heart Disease$87,104
R01 · FY2024 · HL
Targeting Mitochondria in Single Ventricle Heart Disease$675,629
R01 · FY2023 · HL
Targeting Mitochondria in Single Ventricle Heart Disease$161,134
R01 · FY2023 · HL
Targeting Mitochondria in Single Ventricle Heart Disease$686,049
R01 · FY2022 · HL
Targeting Mitochondria in Single Ventricle Heart Disease$161,134
R01 · FY2022 · HL
Targeting Mitochondria in Single Ventricle Heart Disease$723,914
R01 · FY2021 · HL
Targeting mitochondria in SV heart disease$76,211
R01 · FY2021 · HL
Sleep and Blood Pressure-Related Endothelial Abnormalities$716,304
R01 · FY2020 · HL
Sleep and Blood Pressure-Related Endothelial Abnormalities$732,906
R01 · FY2019 · HL
Sleep and Blood Pressure-Related Endothelial Abnormalities$748,784
R01 · FY2018 · HL
Sleep and Blood Pressure-Related Endothelial Abnormalities$777,459
R01 · FY2017 · HL
Molecular and Functional Mechanisms of Pediatric Heart Failure$597,248
R01 · FY2016 · HL · contact PI
Molecular and Functional Mechanisms of Pediatric Heart Failure$543,163
R01 · FY2015 · HL · contact PI
Molecular and Functional Mechanisms of Pediatric Heart Failure$539,577
R01 · FY2014 · HL · contact PI
Molecular and Functional Mechanisms of Pediatric Heart Failure$100,000
R01 · FY2014 · HL · contact PI
Molecular and Functional Mechanisms of Pediatric Heart Failure$523,390
R01 · FY2013 · HL · contact PI
Molecular and Functional Mechanisms of Pediatric Heart Failure$505,889
R01 · FY2012 · HL · contact PI
Molecular and Functional Mechanisms of Pediatric Heart Failure$20,167
R01 · FY2012 · HL · contact PI
Diet, Sex Steroids and Cardiomyopathy$122,820
K08 · FY2011 · HL · contact PI
Cardiac Beta-Adrenergic Adaptation in Pediatric Heart Failure$223,356
R21 · FY2010 · HL · contact PI
Diet, Sex Steroids and Cardiomyopathy$122,820
K08 · FY2010 · HL · contact PI
Cardiac Beta-Adrenergic Adaptation in Pediatric Heart Failure$189,200
R21 · FY2009 · HL · contact PI
Diet, Sex Steroids and Cardiomyopathy$122,820
K08 · FY2009 · HL · contact PI
Diet, Sex Steroids and Cardiomyopathy$122,820
K08 · FY2008 · HL · contact PI
Diet, Sex Steroids and Cardiomyopathy$124,820
K08 · FY2007 · HL · contact PI
The Effect of Gender on Hypertrophic Cardiac Disease.$5,731
F32 · FY2001 · HL